hUC-MSCs have been demonstrated to increase the hepatocyte growth factor (HGF), a multifunctional cytokine that promotes tissue healing via epithelial cells and IFN-γ levels in MS patients [100]. The gene discussed is HGF; the disease is myeloid sarcoma.